-+ 0.00%
-+ 0.00%
-+ 0.00%

The English court said that in most cases, the drug manufacturer's strategy did not disrupt the drug patent linking system, but it also made some unfavorable findings.

Zhitongcaijing·07/10/2026 14:25:05
Listen to the news
The English court said that in most cases, the drug manufacturer's strategy did not disrupt the drug patent linking system, but it also made some unfavorable findings.